Our culture of collaboration is one of WEHI's greatest strengths. Since our earliest years we’ve been building a strong record of successful collaborative projects with private and public partners.

These partnership opportunities, within the Parkville health precinct and now beyond to national and international organisations, offer valuable avenues for us to further our research and translate our discoveries into benefits for patients.

Progress through partnership

With our network of stakeholders we are building a vibrant medical research and education community spanning patient advocacy, business and industry groups, the Victorian and Australian Governments, philanthropic organisations, The University of Melbourne, schools, health care bodies and the community.

WEHI is located in the heart of the Melbourne Biomedical Precinct, home to more than 30 hospitals, research, teaching and biotechnology organisations. Together the precinct partners have established a reputation as Australia’s, and one of the world’s, leading biomedical precincts.

Key collaborators

• Australian Genome Research Facility
• BioGrid Australia
• Biomedical Research Victoria
• Cancer Trials Australia
• Catalyst Therapeutics
• GTAC
• Ian Potter Centre for Genomics and Personalised Medicine
• Melbourne Genomics Health Alliance
• Molecules to Medicine
• The Royal Melbourne Hospital
• Stem Cells Australia
• The University of Melbourne
• Type 1 Diabetes Trialnet
• Victorian Comprehensive Cancer Centre (VCCC)
• Victorian Government
• Victorian Infection and Immunity Network
• Volunteer Blood Donor Registry

Start-up companies

WEHI has established several companies to facilitate research translation and to promote further collaboration. Among these are biotechnology and drug development companies, including Genera Biosystems, Murigen Therapeutics and Anaxis Pharma Pty Ltd.